Clinical Trial to Treat Ependymoma

Clinical Trial to Treat Ependymoma

04/10/2020 10:58 AM EDT

Neuro-oncologist Mark Gilbert, M.D., shares information about a clinical trial at NIH investigating the effectiveness of a drug to treat people with recurrent ependymoma. He explains the goal of the trial, who can participate and how, and what a patient can expect. Trial ID 19-C-0011. Learn more at www.cancer.gov/clinicaltrials/NCI-2018-02730.